News
CNSP
0.2140
+1.90%
0.0040
Weekly Report: what happened at CNSP last week (0415-0419)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. NKGen Biotech and T2 Biosystems moved upwards. Vaxxinity stock declined by 61.3% during the session.
Benzinga · 2d ago
Weekly Report: what happened at CNSP last week (0408-0412)?
Weekly Report · 04/15 12:25
CNS Pharmaceuticals: Current report
Press release · 04/15 12:04
CNS Pharmaceuticals Conducts Informational Investor Meetings
TipRanks · 04/15 10:22
12 Health Care Stocks Moving In Friday's After-Market Session
Qilian Intl Hldg Gr (NASDAQ:QLI) stock moved upwards by 50.4% to $1.14 during Friday's after-market session. Allarity Therapeutics stock rose 18.09% and Galecto stock increased by 5.58%. PaxMedica stock declined by 8.0% during the session.
Benzinga · 04/12 20:31
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Etao International Co (NASDAQ:ETAO) stock moved upwards by 96.6% to $4.9 during Monday's regular session. Adlai Nortye stock rose 47.3% and Longeveron shares rose 48.63% during the session. Losers include Universe Pharmaceuticals, Agenus and Vincerx Pharma.
Benzinga · 04/08 16:31
Weekly Report: what happened at CNSP last week (0401-0405)?
Weekly Report · 04/08 12:31
CNS Pharmaceuticals Q4 EPS $(0.95) Up From $(3.82) YoY
Benzinga · 04/02 12:10
CNS Pharmaceuticals: Annual report
Press release · 04/02 02:22
Weekly Report: what happened at CNSP last week (0325-0329)?
Weekly Report · 04/01 12:27
Weekly Report: what happened at CNSP last week (0318-0322)?
Weekly Report · 03/25 12:30
Weekly Report: what happened at CNSP last week (0311-0315)?
Weekly Report · 03/18 12:29
Weekly Report: what happened at CNSP last week (0304-0308)?
Weekly Report · 03/11 12:23
Weekly Report: what happened at CNSP last week (0226-0301)?
Weekly Report · 03/04 12:28
CNS Pharmaceuticals Strives to Regain Nasdaq Compliance
TipRanks · 02/27 22:33
Weekly Report: what happened at CNSP last week (0219-0223)?
Weekly Report · 02/26 12:49
Weekly Report: what happened at CNSP last week (0212-0216)?
Weekly Report · 02/19 12:51
Weekly Report: what happened at CNSP last week (0205-0209)?
Weekly Report · 02/12 12:35
Top 5 Health Care Stocks That Are Preparing To Pump In February
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. An asset is typically considered oversold when the RSI has an RSI near or below 30.
Benzinga · 02/09 13:35
More
Webull provides a variety of real-time CNSP stock news. You can receive the latest news about CNS Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About CNSP
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.